UW Quitting Using Intensive Treatment Study (QUITS)
Status:
Completed
Trial end date:
2020-07-09
Target enrollment:
Participant gender:
Summary
This research will determine whether two highly promising modifications to varenicline
treatment (i.e. use of a nicotine patch adjuvant and extended 24-week duration) produce
superior smoking outcomes when they are either used together or alone. Despite their promise,
the proposed modifications have never been experimentally evaluated relative to standard
varenicline pharmacotherapy. Thus, this innovative research will produce novel evidence
regarding how best to help smokers quit, and thereby address the leading cause of preventable
mortality and morbidity related to cardiovascular and pulmonary diseases.
Phase:
Phase 4
Details
Lead Sponsor:
University of Wisconsin, Madison
Collaborators:
National Heart, Lung, and Blood Institute (NHLBI) Washington University School of Medicine